Evidence map›Paper›PMID 40994741›Full record

ArticleBlood neoplasia2025

Eμ-TCL1 mice with conditional human BCL2 knockin as novel B-cell lymphoma model for studying venetoclax effects in vivo.

Ismini Halmer, Daniela Asslaber, Laura Beckmann, Gero Knittel, Hans Christian Reinhardt, Hamid Kashkar, Michael Hallek, Jens Löber, Björn Chapuy, Alexander Egle and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood neoplasia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ismini HalmerDepartment I of Internal Medicine, Center for Integrated Oncology Aachen, Faculty of Medicine and Cologne University Hospital, University of Cologne, Cologne, Germany.
Daniela AsslaberDepartment of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute and Cancer Cluster Salzburg, Salzburg, Austria.
Laura BeckmannDepartment I of Internal Medicine, Center for Integrated Oncology Aachen, Faculty of Medicine and Cologne University Hospital, University of Cologne, Cologne, Germany.
Gero KnittelDepartment of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Hans Christian ReinhardtDepartment of Hematology and Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Hamid KashkarCologne Cluster of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany.
Michael HallekDepartment I of Internal Medicine, Center for Integrated Oncology Aachen, Faculty of Medicine and Cologne University Hospital, University of Cologne, Cologne, Germany.
Jens LöberDepartment of Hematology, Oncology and Tumor Immunology, Charité, Campus Benjamin Franklin, University Medicine Berlin, Berlin, Germany.
Björn ChapuyDepartment of Hematology, Oncology and Tumor Immunology, Charité, Campus Benjamin Franklin, University Medicine Berlin, Berlin, Germany.
Alexander EgleDepartment of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute and Cancer Cluster Salzburg, Salzburg, Austria.
Günter KrauseDepartment I of Internal Medicine, Center for Integrated Oncology Aachen, Faculty of Medicine and Cologne University Hospital, University of Cologne, Cologne, Germany.
Alexandra da Palma GuerreiroDepartment I of Internal Medicine, Center for Integrated Oncology Aachen, Faculty of Medicine and Cologne University Hospital, University of Cologne, Cologne, Germany.
Lukas P FrenzelDepartment I of Internal Medicine, Center for Integrated Oncology Aachen, Faculty of Medicine and Cologne University Hospital, University of Cologne, Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40994741
PMCPMC12454994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.